BioChain: Pioneers in Providing High Quality Testing Reagents in the Fight Against COVID-19

Today BioChain announced it has successfully provided enough reagents to test over 3,000,000 people across the United States for COVID-19 infection.

Today BioChain announced it has successfully provided enough reagents to test over 3,000,000 people across the United States for COVID-19 infection. This is due to the recent launch of their vamPure Viral Nucleic Acid Extraction kit, which allows for fast and efficient total nucleic acid extraction from human swab samples. The final extract is ideal for subsequent detection of various viral species, including the novel coronavirus responsible for COVID-19 disease. BioChain’s new kit has been hailed as a high quality, cost effective, sensitive, and reliable tool by clinical labs that need to process tens of thousands of test samples per day. BioChain’s vamPure Viral kit is easy to use and ideal for application on automation platforms, which greatly facilitates acquisition of test results. The kit can be purchased in small quantities or bulk packaging depending on the customer’s needs.

BioChain Institute

For info: 888-762-2568

www.biochain.com

MORE ON THIS TOPIC